Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Subin | - |
dc.contributor.author | Kim, Bung-Nyun | - |
dc.contributor.author | Kim, Jae-Won | - |
dc.contributor.author | Shin, Min-Sup | - |
dc.contributor.author | Cho, Soo-Churl | - |
dc.contributor.author | Kim, Ji-Hoon | - |
dc.contributor.author | Son, Jung-Woo | - |
dc.contributor.author | Shin, Yun-Mi | - |
dc.contributor.author | Chung, Un-Sun | - |
dc.contributor.author | Han, Doug-Hyun | - |
dc.date.available | 2019-03-08T22:02:29Z | - |
dc.date.issued | 2014-03 | - |
dc.identifier.issn | 0269-8811 | - |
dc.identifier.issn | 1461-7285 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/12431 | - |
dc.description.abstract | Neurotrophin 3 (NTF3) has been studied in relation to the pathophysiology of attention-deficit/hyperactivity disorder (ADHD) and mood disorders as well as psychostimulant action. We hypothesized that the risk of an emotional side effect to methylphenidate (MPH) treatment may be associated with NTF3 genotypes. Ninety-six medication-naive children with ADHD (mean age 8.70, standard deviation 1.41 years, 79 males) were genotyped and treated with MPH. At baseline, which was prior to MPH treatment, and after two weeks of medication, investigators asked children and their parents or caregivers about adverse events using a symptom rating scale. ADHD subjects with the A/A genotype at the NTF3 rs6332 polymorphism showed the highest 'Emotionality' and 'Over-focus/euphoria' factor scores, followed by those with the G/A genotype and those with the G/G genotype (p=0.042 and p=0.045, respectively). ADHD subjects with the A/A genotype at the NTF3 rs6332 polymorphism showed the highest 'Proneness to crying' and 'Nail biting' item scores, followed by those with the G/A genotype and those with the G/G genotype (p=0.047 and p=0.017, respectively). These data provide preliminary evidence that genetic variation in the NTF3 gene is related to susceptibility to emotional side effects in response to MPH treatment in Korean children with ADHD. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SAGE PUBLICATIONS LTD | - |
dc.title | Neurotrophin 3 genotype and emotional adverse effects of osmotic-release oral system methylphenidate (OROS-MPH) in children with attention-deficit/hyperactivity disorder | - |
dc.type | Article | - |
dc.identifier.doi | 10.1177/0269881113480989 | - |
dc.identifier.bibliographicCitation | JOURNAL OF PSYCHOPHARMACOLOGY, v.28, no.3, pp 220 - 226 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000332060100004 | - |
dc.identifier.scopusid | 2-s2.0-84895516385 | - |
dc.citation.endPage | 226 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 220 | - |
dc.citation.title | JOURNAL OF PSYCHOPHARMACOLOGY | - |
dc.citation.volume | 28 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | emotional side effect | - |
dc.subject.keywordAuthor | neurotrophin 3 | - |
dc.subject.keywordAuthor | Attention-deficit/hyperactivity disorder | - |
dc.subject.keywordPlus | DEFICIT HYPERACTIVITY DISORDER | - |
dc.subject.keywordPlus | DOPAMINE TRANSPORTER GENOTYPE | - |
dc.subject.keywordPlus | DOSE-RESPONSE | - |
dc.subject.keywordPlus | RAT-BRAIN | - |
dc.subject.keywordPlus | ADHD | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | ADULT | - |
dc.subject.keywordPlus | SUSCEPTIBILITY | - |
dc.subject.keywordPlus | SCHIZOPHRENIA | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Psychiatry | - |
dc.relation.journalWebOfScienceCategory | Clinical Neurology | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Psychiatry | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.